iPS cell smack down

Pity the iPS cell -- it's had quite a ride this year. On the upside, cells reprogrammed from people with autism, Parkinson's disease and schizophrenia were used to create the first ever models of those diseases in a dish. Those models could provide a way of testing drugs on actual human cells. That's good.

Reducing teratoma risk from transplanted stem cells

By Paul Knoepfler

The two most serious obstacles to regenerative medicine therapies are potential immune rejection of transplanted cells and the possibility that such cells could form a type of tumor called teratoma.

Genetic Brake Key to Stem Cell Fate

Researchers at UC, Santa Barbara, have mapped the role of a genetic signal that puts the breaks on the ability of stem cells to self renew.

Subscribe to RSS - Xu

© 2013 California Institute for Regenerative Medicine